30th November 2021
- 0 comments
British Patient Capital has participated in Quell Therapeutics’ $156m Series B funding round. The deal is the first life sciences investment from Future Fund: Breakthrough, a £375m programme where British Patient Capital co-invests with private sector investors in innovative R&D-intensive UK companies.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage